One study reports a reduction in TREM2 RNA levels before the onset of pathology in Tg2576 mice [209], though after the onset of pathology, all amyloid models of AD examined have increased TREM2 RNA and protein levels [162, 200, 210–214]. The gene discussed is TREM2; the disease is amyloidosis.